Languages
Pages
Legal
Explore all categories to find your favorite topic
Sirolimus-Eluting Balloon with Sustained Release Proprietary Micro-reservoir Technology • Creation of micro-reservoirs combining sirolimus biodegradable polymer • Sirolimus…
Slide 1 A Randomized Comparison of a Sirolimus-eluting Stent with Biodegradable Polymer versus an Everolimus-eluting Stent with a Durable Polymer for Percutaneous Coronary…
A breakthrough in drug-eluting balloon technology S ELUTION SLR Sirolimus-Eluting Balloon two-year results demonstrate excellent safety and efficacy in treating SFA and popliteal…
Effectiveness of Complete Lesion Effectiveness of Complete Lesion Coverage with Coverage with SirolimusSirolimus--Eluting Eluting StentStent for for OstialOstial Left Anterior…
1. © Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2015;5(2):113-121www.thecdt.org Introduction Permanent polymers of first generation…
review article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 3683 nejm.org january 17, 2013254 Drug Therapy Drug-Eluting Coronary-Artery Stents Giulio…
The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent Michael Haude, MD On behalf of the REMEDEE…
Drug-eluting stents DESs have mitigated the issue of restenosis inherent to bare metal stents1 In addition new-generation DESs have addressed concerns of very late stent…
1 Diabetes mellitus is an established risk factor of atheroscle-rosis1 and restenosis after percutaneous coronary inter- ventions PCI.2 New-generation drug-eluting stents…
Journal Papers 1-44 1. Mäkikallio, Timo et al., Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis NOBLE:…
oktober 21 2007 DEB for Bifurcations 1 A Paclitaxel-Eluting Balloon for Bifurcation Lesions : ‘ Early Clinical Observations ‘ Pieter R Stella MD Director CardioVascular…
Online Table 1. Clinical Outcomes During Follow-up in ST-elevation MI Patients Following Primary Percutaneous Coronary Intervention n=5492 Outcomes BP-DES group n=1166 Second-generation…
174 CASE REPORT Korean Circ J 200838:174-178 Print ISSN 1738-5520 On-line ISSN 1738-5555 Copyright ⓒ 2008 The Korean Society of Cardiology A Case of Late Recurrent Vasospasm…
2-year outcome of the 3-arm BIO-RESORT randomized trial in all-comer patients treated with contemporary DES Marlies M Kok MD Thoraxcentrum Twente MST Enschede the Netherlands…
1 DRG-Heft 2020 BIOTRONIK Reimbursement 39Elektrophysiologie AlCath Ablationskatheter mit Goldelektroden Flexibel: Erreichbarkeit der anatomischen Strukturen durch 270 Grad…
Sirolimus-eluting Stents: Present and Future Dr Steve Fearn Director of Health Economics and Medical Affairs Cordis UK Conflict of Interest I am employed by Cordis. Topics…
Ultrathin 65 µm Design Excellent Deliverability Degradable Polymermatrix Synchronized Polymerdegradation and Drug Release Wide Range of Diameters up to 5.0 mm Stent
Two-Year Outcomes of High Bleeding Risk Patients after Polymer-Free Drug-Coated Stents Philip Urban Philippe Garot Damras Tresukosol…
Slide 1OPTIMIZE: A Prospective, Randomized Trial of 3 Months Versus 12 Months of Dual Antiplatelet Therapy with the Endeavor Zotarolimus-Eluting Stent Fausto Feres, MD, PhD…
Slide 1 ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli, MD Klinikum…